SEC Form 4 · accession 0001209191-15-085125
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Walbert
Officer — Chairman, President and CEO · Director
Period of report
Dec 11, 2015
Accepted (ET)
Dec 14, 2015 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Dec 11, 2015 | M | 2,082 | $4.96 | A | 205,788 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.96 | Dec 11, 2015 | M | 2,082 | D | — | Dec 7, 2021 | Ordinary Shares | 2,082 | 196,794 | D |
Explanation of responses
- F1The stock option vests in 48 equal monthly installments following the date of grant.